What is OS Therapies's common stock?

OS Therapies (OSTX) reported common stock of 150M in Q1 2026.

How has OS Therapies's common stock changed year-over-year?

OS Therapies's common stock increased by 200.0% year-over-year, from 50M to 150M.

What is the long-term trend for OS Therapies's common stock?

Over 2 years (2023 to 2025), OS Therapies's common stock has grown at a 73.2% compound annual growth rate (CAGR), from 50M to 150M.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

OS Therapies OSTX Common Stock

Common Stock at other companies

ImmunomeIMNM

$11K+22.2%

CTO

Citius Oncology, Inc.CTOR

400M+300%

Avalo TherapeuticsAVTX

200M0.0%

Arcus BiosciencesRCUS

400M0.0%

ImmunityBio, Inc.IBRX

1.7B+22.2%

WHW

Whitehawk Therapeutics, Inc. Common StockWHWK

$4K-100.0%

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+66.4%

Enterprise value$103.7M—

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's common stock?: OS Therapies (OSTX) reported common stock of 150M in Q1 2026.
How has OS Therapies's common stock changed year-over-year?: OS Therapies's common stock increased by 200.0% year-over-year, from 50M to 150M.
What is the long-term trend for OS Therapies's common stock?: Over 2 years (2023 to 2025), OS Therapies's common stock has grown at a 73.2% compound annual growth rate (CAGR), from 50M to 150M.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).